Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqCM:EXAS
NasdaqCM:EXASBiotechs

Did Oncotype DX’s 2 Millionth Patient Milestone Just Shift Exact Sciences’ (EXAS) Investment Narrative?

In early February 2026, Exact Sciences reported that its Oncotype DX Breast Recurrence Score test has now guided treatment decisions for more than two million early-stage HR+, HER2- breast cancer patients worldwide, supported by over two decades of clinical evidence and broad global adoption. The company highlighted that Oncotype DX remains the only genomic assay proven to be both prognostic and predictive for chemotherapy benefit, with published models suggesting meaningful lifetime cost...
NYSE:MTH
NYSE:MTHConsumer Durables

A Look At Meritage Homes (MTH) Valuation After Earnings, Buybacks And Flat 2026 Revenue Guidance

Meritage Homes (MTH) is back in focus after its latest earnings release, which combined lower annual revenue and net income with real estate impairments, flat 2026 revenue guidance, sizable buybacks, and record community growth. See our latest analysis for Meritage Homes. At a share price of $75.91, Meritage Homes has seen stronger recent momentum, with a 7 day share price return of 8.15% and a 90 day share price return of 10.21%. Its 5 year total shareholder return of 83.21% shows how the...
NYSE:EE
NYSE:EEOil and Gas

How Excelerate Energy’s Earnings Surprise Pattern And ESP Signal (EE) Has Changed Its Investment Story

Recent research coverage highlights Excelerate Energy’s history of outperforming earnings estimates, pointing to past quarterly surprises and a current positive Earnings ESP, with the next report scheduled for February 25, 2026. An interesting angle is how the combination of a positive Earnings ESP and a mid-range Zacks Rank is shaping expectations around Excelerate Energy’s ability to outpace consensus forecasts. With this backdrop of anticipated earnings outperformance, we’ll explore what...
TSX:TVE
TSX:TVEOil and Gas

Tamarack Valley Energy (TSX:TVE) Valuation Check After Free Cash Flow Update And Firmer Oil Prices

Tamarack Valley Energy (TSX:TVE) is back in focus after reaffirming its operational priorities and updating guidance for robust free cash flow, a shift that comes as firmer oil prices support renewed investor attention. See our latest analysis for Tamarack Valley Energy. That operational update comes on the back of firm momentum, with a 30 day share price return of 23.74% and a 90 day share price return of 38.58%. The 1 year total shareholder return of 117.02% and 5 year total shareholder...
NasdaqGS:DNLI
NasdaqGS:DNLIBiotechs

Assessing Denali Therapeutics (DNLI) Valuation After WORLDSymposium Clinical Updates And Regulatory Progress

Denali Therapeutics (DNLI) has drawn fresh attention after presenting clinical and preclinical data at the 22nd Annual WORLDSymposium, updating investors on its Enzyme Transport Vehicle programs and upcoming regulatory milestones for rare disease candidates. See our latest analysis for Denali Therapeutics. Those WORLDSymposium updates and the recent shareholder and analyst call come after a 90 day share price return of 35.13% and a 30 day share price return of 23.42%. However, the 1 year...